EBioMedicine (Sep 2024)

NMR metabolomics-guided DNA methylation mortality predictorsResearch in context

  • Daniele Bizzarri,
  • Marcel J.T. Reinders,
  • Lieke Kuiper,
  • Marian Beekman,
  • Joris Deelen,
  • Joyce B.J. van Meurs,
  • Jenny van Dongen,
  • René Pool,
  • Dorret I. Boomsma,
  • Mohsen Ghanbari,
  • Lude Franke,
  • Pieternella E. Slagboom,
  • Erik B. van den Akker,
  • J.M. Geleijnse,
  • E. Boersma,
  • W.E. van Spil,
  • M.M.J. van Greevenbroek,
  • C.D.A. Stehouwer,
  • C.J.H. van der Kallen,
  • I.C.W. Arts,
  • F. Rutters,
  • J.W.J. Beulens,
  • M. Muilwijk,
  • P.J.M. Elders,
  • L.M. 't Hart,
  • M. Ghanbari,
  • M.A. Ikram,
  • M.G. Netea,
  • M. Kloppenburg,
  • Y.F.M. Ramos,
  • N. Bomer,
  • I. Meulenbelt,
  • K. Stronks,
  • M.B. Snijder,
  • A.H. Zwinderman,
  • B.T. Heijmans,
  • L.H. Lumey,
  • C. Wijmenga,
  • J. Fu,
  • A. Zhernakova,
  • J. Deelen,
  • S.P. Mooijaart,
  • M. Beekman,
  • P.E. Slagboom,
  • G.L.J. Onderwater,
  • A.M.J.M. van den Maagdenberg,
  • G.M. Terwindt,
  • C. Thesing,
  • M. Bot,
  • B.W.J.H. Penninx,
  • S. Trompet,
  • J.W. Jukema,
  • N. Sattar,
  • I.C.C. van der Horst,
  • P. van der Harst,
  • C. So-Osman,
  • J.A. van Hilten,
  • R.G.H.H. Nelissen,
  • I.E. Höfer,
  • F.W. Asselbergs,
  • P. Scheltens,
  • C.E. Teunissen,
  • W.M. van der Flier,
  • J. van Dongen,
  • R. Pool,
  • A.H.M. Willemsen,
  • D.I. Boomsma,
  • H.E.D. Suchiman,
  • J.J.H. Barkey Wolf,
  • M. Beekman,
  • D. Cats,
  • H. Mei,
  • M. Slofstra,
  • M. Swertz,
  • M.J.T. Reinders,
  • E.B. van den Akker,
  • D.I. Boomsma,
  • M.A. Ikram,
  • P.E. Slagboom

Journal volume & issue
Vol. 107
p. 105279

Abstract

Read online

Summary: Background: 1H-NMR metabolomics and DNA methylation in blood are widely known biomarkers predicting age-related physiological decline and mortality yet exert mutually independent mortality and frailty signals. Methods: Leveraging multi-omics data in four Dutch population studies (N = 5238, ∼40% of which male) we investigated whether the mortality signal captured by 1H-NMR metabolomics could guide the construction of DNA methylation-based mortality predictors. Findings: We trained DNA methylation-based surrogates for 64 metabolomic analytes and found that analytes marking inflammation, fluid balance, or HDL/VLDL metabolism could be accurately reconstructed using DNA-methylation assays. Interestingly, a previously reported multi-analyte score indicating mortality risk (MetaboHealth) could also be accurately reconstructed. Sixteen of our derived surrogates, including the MetaboHealth surrogate, showed significant associations with mortality, independent of relevant covariates. Interpretation: The addition of our metabolic analyte-derived surrogates to the well-established epigenetic clock GrimAge demonstrates that our surrogates potentially represent valuable mortality signal. Funding: BBMRI-NL, X-omics, VOILA, Medical Delta, NWO, ERC.

Keywords